Your browser doesn't support javascript.
loading
Factors Affecting the Clinical Course of Follicular Lymphoma: A Multistate Survival Analysis Using Individual Patient Data from Eight Multicenter Randomized Clinical Trials.
Dixon, Jesse G; Çaglayan, Çaglar; Chihara, Dai; Nielsen, Tina; Dimier, Natalie; Zheng, Jamie; Wall, Anna K; Salles, Gilles; Morschhauser, Franck; Marcus, Robert; Herold, Michael; Kimby, Eva; Blum, Kristie A; Ghielmini, Michele; Shi, Qian; Flowers, Christopher R.
Afiliação
  • Dixon JG; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN. Electronic address: dixon.jesse@mayo.edu.
  • Çaglayan Ç; Asymmetric Operations Sector, Johns Hopkins University Applied Physics Laboratory, Laurel, MD.
  • Chihara D; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, University of Texas, Houston, TX.
  • Nielsen T; Department of Biostatistics, Roche Products Ltd, Welwyn Garden City, Hertfordshire, United Kingdom.
  • Dimier N; Department of Biostatistics, Roche Products Ltd, Welwyn Garden City, Hertfordshire, United Kingdom.
  • Zheng J; Bristol-Myers Squibb, Summit, NJ.
  • Wall AK; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Salles G; Division of Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Morschhauser F; Department of Hematology, University of Lille, Lille, Hauts-de-France, France.
  • Marcus R; Department of Haematology, Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom.
  • Herold M; Helios Klinikum Erfurt, Onkologisches Zentrum, Erfurt, Thuringia, Germany.
  • Kimby E; Unit for Hematology Karolinska University Hospital, Stockholm, Sweden.
  • Blum KA; Department of Hematology and Medical Oncology, Emory University, Atlanta, GA.
  • Ghielmini M; Department of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Ticino, Switzerland.
  • Shi Q; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
  • Flowers CR; Department of Lymphoma/Myeloma, MD Anderson Cancer Center, University of Texas, Houston, TX.
Clin Lymphoma Myeloma Leuk ; 22(11): e1009-e1018, 2022 11.
Article em En | MEDLINE | ID: mdl-36045021
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Systematic_reviews Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article